Providing Chelation Therapy since 1994

Dr Garner is board certified in Chelation Therapy. Call the office for a Chelation Consultation. 518.798.9401

What is Chelation Therapy?

To chelate something literally means “to grab” or “to bind.”  Chelation therapy has come to mean taking EDTA (ethylenediaminetetraacetic acid)—and injecting it into the bloodstream to remove heavy metals from the body.   When EDTA is injected into the body, it “binds” heavy metals such as lead, mercury, nickel, cadmium, arsenic, and aluminum. These Metal-EDTA complexes are removed from the body through the kidneys. There is no processing required of these metal complexes by the kidneys.

EDTA has a preference for different metal ions and based on the concentration in the body and the affinity coefficient, it will remove these toxic metals from the body in a systematic manner. Chelation Therapy is usually given in a series of treatments with a urine test for the heavy metals before and after treatment.

Interested In Chelation Therapy?

The following are the most commonly asked questions about Chelation Therapy.

Heavy metals are everywhere- they are in our air, in our food, and in our water. We are all exposed to them. I believe that there is a genetic defect in some individuals that causes them to hold on to these metals more than others; as we are all exposed to these same metals, but not everyone accumulates them to the same degree.

This is obviously not true if you have some sort of unique exposure like one of my patients. She grew up in a home as a child with parents who were painters. In those days, her parents would mix their own paint from powdered pigments that they had lying around the house in open piles. In those days there was lead in the pigments. Fortunately, not many of us have this sort of exposure but we all are constantly exposed to them in one degree or another.

They took lead out of our gasoline in the 70’s…where did all that lead go; it was exhausted out of our vehicles along our highways. In the majority of our country the farmers’ fields are along the highways, so the lead is in the earth and in our food chain. It doesn’t get washed down the storm sewers.

Back in the 1950’s, workers in the lead battery manufacturing industry in Detroit developed lead poisoning from absorption of the lead through their skin . This was before OSHA and the protection of workers became the appropriate norm.

A drug had to be developed to save their lives. EDTA was developed as an FDA approved drug to treat this lead toxicity. Some of the workers who had angina found that their angina got better when their elevated lead levels were treated. Thus a grass roots effort to treat angina was born.

It is very easy to test for the presence of heavy metals. First the patient is given five days of oral EDTA, then on the sixth day they are brought to the office and an IV dose of 30 mg per kilogram is administered. The patient collects their urine for the next 12 hours and then it is sent to a laboratory for testing for 20 different metals.

Speaking of oral EDTA, it is never enough by itself to remove heavy metals from a patient who has a significant burden of metals. It’s only about 10% absorbed into the bloodstream. IV EDTA is required to remove these heavy metals from the human body. We do however, recommend using oral EDTA while doing the IV EDTA to make sure that we are keeping a continuous blood level and therefore continuously pulling at least a little bit of metals out, rather than continuing to be a sponge and soak up these metals from our constant day-to-day exposure. Having EDTA in our intestinal tract also helps block the absorption of metals into our body from our foodstuff.

Heavy metals affect many different systems in our bodies. Their presence can cause dysfunction of the immune system, basic normal energy production/metabolism, and cause other medical problems that we have developed, to be harder to treat due to their presence. Removal of these metals is imperative to restoring good health.

It is administered as an IV infusion into your vein. This is done in a medical office.

A minimum of 30 treatments is recommended, followed by a monthly maintenance dose. The total number of treatments is determined by the results of your heavy metal testing.

Serious side-effects are rare, especially when the treatment is performed by providers that are properly trained. As with any IV administration, it is possible to have discomfort at the injection site or to develop an infection. Also, any drug can cause an allergic reaction, but this is rare and medical offices are prepared to deal with these emergencies. You should not have Chelation therapy if you have had tuberculosis as it can potentially reactivate TB. If you have kidney disease, your dose of Chelation will be adjusted appropriately. Studies have shown that Chelation Therapy benefits renal function in patients with renal disease.

Because it is considered an alternative treatment, Chelation therapy is not covered by insurance except with some cases of heavy metal poisoning proven by elevated blood levels and certain symptoms.

For more information you can visit: gordonresearch.com, nhlbi.nih.gov, or nccam.nih.gov.

Please setup a consultation with Dr. Garner to discuss the Chelation program that is right for you.

National Institute of Health commissions a study on Chelation Therapy

The Trial to Assess Chelation Therapy (TACT) was published in the Journal of the American Medical Association on March 27, 2013.

TACT is the first large-scale study designed to determine the efficacy of Chelation therapy using EDTA for individuals who suffered prior heart attacks. The National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) and National Center for Complementary and Alternative Medicine (NCCAM) co-sponsored the TACT trial.

https://clinicaltrials.gov/ct2/show/NCT00044213

It was designed to be large enough to detect if there are any moderate benefits or risks associated with the therapy so they enrolled  over 1700 patients.

The researchers concluded that TACT provides evidence that a regimen of 40 infusions of disodium EDTA modestly reduced the risk of some cardiovascular events in adults who have previously had a heart attack.  This treatment effect lasted during the 5-year follow-up period.

Overall, those receiving Chelation had an 18 percent reduced risk of subsequent cardiovascular events such as heart attack, stroke, hospitalization for angina, or coronary revascularization or death from any cause. A cardiovascular event occurred in 222 (26 percent) of the Chelation group and 261 (30 percent) of the placebo group. Two subgroups of participants had a greater reduction in risk for cardiovascular events. Those with diabetes had a 39 percent reduction in risk and those who had experienced a specific type of heart attack, called an anterior myocardial infarction, had a 37 percent reduction in risk. There were no increased risks associated with the group who received Chelation vs. the placebo group.

Several of my patients have gone 16 or more years without a cardiovascular event after Chelation Therapy. I believe that a long term study would show that the benefit of Chelation Therapy vs. conventional therapy would continue to show reduction in risk.

EDTA is approved for removing lead for heavy metal toxicity. Treating heart disease with EDTA Chelation therapy is legal, but it is considered an “off-label” use of the drug.